Your browser doesn't support javascript.
loading
Quality of life with first-line pembrolizumab for PD-L1-positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study.
Van Cutsem, E; Valderrama, A; Bang, Y-J; Fuchs, C S; Shitara, K; Janjigian, Y Y; Qin, S; Larson, T G; Shankaran, V; Stein, S; Norquist, J M; Kher, U; Shah, S; Alsina, M.
Affiliation
  • Van Cutsem E; Department of Digestive Oncology, University Hospital Gasthuisberg Leuven and KU Leuven, Leuven, Belgium. Electronic address: eric.vancutsem@uzleuven.be.
  • Valderrama A; Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, USA.
  • Bang YJ; Department of Biomedical Research, Seoul National University College of Medicine, Seoul, South Korea.
  • Fuchs CS; Department of Internal Medicine: Hematology, Medical Oncology, Gastro-oncology, Yale University Cancer Center, Smilow Cancer Hospital, New Haven, USA.
  • Shitara K; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Janjigian YY; Department of Gastrointestinal Oncology, Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Qin S; Cancer Center, PLA Cancer Centre of Nanjing Bayi Hospital, Nanjing, China.
  • Larson TG; Department of Hematology/Oncology, Minnesota Oncology Hematology, Minneapolis.
  • Shankaran V; Department of Medical Oncology, Seattle Cancer Care Alliance, Seattle.
  • Stein S; Department of Internal Medicine: Hematology, Medical Oncology, Gastro-oncology, Yale University Cancer Center, Smilow Cancer Hospital, New Haven, USA.
  • Norquist JM; Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, USA.
  • Kher U; Department of Medical Oncology, Merck & Co., Inc., Kenilworth, USA.
  • Shah S; Department of Medical Oncology, Merck & Co., Inc., Kenilworth, USA.
  • Alsina M; Department of Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona; University Autònoma de Barcelona, Barcelona, Spain.
ESMO Open ; 6(4): 100189, 2021 08.
Article in En | MEDLINE | ID: mdl-34371381
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Adenocarcinoma Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Adenocarcinoma Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article